Novel Coronavirus (SARS-CoV-2/COVID-19)
A new analysis prepared for the AHA by Kaufman, Hall & Associates LLC highlights COVID-19’s dire impact on hospitals’ and health systems’ financial health.
As the rates of COVID-19 continue to rise in certain areas across the country, the need for greater coordination and even an expanded health care workforce may become critical. There are several organizations with the interest and the capacity to help partner with hospitals and health systems to be…
This is an AHA member-only video. It will only play if you are a member.
Your browser does not support the video tag.
If you are a member and the video did not automatically begin to play, please click the button below and login in using you member credentials. You will then be taken to a…
AHA President and CEO Rick Pollack, AHA Executive Vice President Tom Nickels and AHA Senior Vice President of Public Policy Analysis and Development Ashley Thompson provided the latest from Capitol Hill and then hospital leaders urged their senators to provide additional resources to hospitals and…
A new analysis prepared by Kaufman, Hall & Associates, LLC and released by the AHA today highlights the dire impact of the COVID-19 crisis on the financial health of hospitals and health systems. Without further government support, margins could sink to -7% in the second half of 2020, according…
A new analysis prepared by Kaufman, Hall & Associates, LLC and released by the American Hospital Association highlights the dire impact of the COVID-19 crisis on the financial health of hospitals and health systems.
Harvard University’s Kennedy School, the Stanford Institute for Human-Centered Artificial Intelligence and the United Nations recently collaborated on a platform to produce a decision-making tool that initially will focus on digital contact tracing of coronavirus infections. The platform, which…
The Food and Drug Administration last week reissued its emergency use authorization of Quest Diagnostics’ SARS-CoV-2 rRT-PCR test for use with pooled samples containing up to four individual swab specimens collected under observation.
The New England Journal of Medicine last week released a study showing that the use of dexamethasone resulted in a lower, 28-day mortality rate among patients receiving invasive ventilation or oxygen.
A COVID-19 trial vaccine developed by the University of Oxford and AstraZeneca produced neutralizing antibody responses in patients with SARS-CoV-2, according to a study published July 20 in The Lancet.